Prana commences research collaboration with Takeda for the treatment of Parkinson’s disease gastrointestinal neuropathology July 18, 2017August 16, 2022
Alterity’s ATH434 Prevents Loss of Brain Cells in Parkinson’s Disease Animal Model January 30, 2023May 23, 2023
Prana Appoints David Stamler as Chief Medical Officer to Lead Clinical Development June 5, 2017August 16, 2022